Literature DB >> 15474104

Intratympanic corticosteroids for Meniere's disease and vertigo.

David M Barrs1.   

Abstract

Hearing loss can be caused by acoustic trauma, aging, ototoxic medications, and various other causes. At the cellular level hearing loss seems to be mediated by reactive oxygen species and ultimately through the activation of apoptotic mechanisms. This article explains the cellular and molecular mechanisms of hearing loss and presents medications that could be used in the intratympanic treatment of hearing loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474104     DOI: 10.1016/j.otc.2004.03.004

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  8 in total

Review 1.  Principles of local drug delivery to the inner ear.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

2.  Evaluation of intratympanic dexamethasone for treatment of refractory sudden sensorineural hearing loss.

Authors:  Yao-wen Wang; Ji-hao Ren; Yong-de Lu; Tuan-fang Yin; Ding-hua Xie
Journal:  J Zhejiang Univ Sci B       Date:  2012-03       Impact factor: 3.066

3.  Low dose combination steroids control autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  J Neuroimmunol       Date:  2010-08-30       Impact factor: 3.478

4.  The protective effects of systemic dexamethasone on sensory epithelial damage and hearing loss in targeted Cx26-null mice.

Authors:  Kai Xu; Sen Chen; Le Xie; Yue Qiu; Xiao-Zhou Liu; Xue Bai; Yuan Jin; Xiao-Hui Wang; Yu Sun
Journal:  Cell Death Dis       Date:  2022-06-10       Impact factor: 9.685

5.  Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

6.  Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.

Authors:  Hongzhuo Liu; Liang Feng; Gaurav Tolia; Mark R Liddell; Jinsong Hao; S Kevin Li
Journal:  Drug Dev Ind Pharm       Date:  2013-04-30       Impact factor: 3.225

7.  Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere's Disease.

Authors:  Sasan Dabiri Satri; Reza Gharibi; Farzaneh Nejadian; Nasrin Yazdani; Reza Hoseinabadi; Nima Rezazadeh; Mohammad Reza Firouzifar; Saeed Babaei
Journal:  Iran J Otorhinolaryngol       Date:  2017-05

8.  Cochlear Glucocorticoid Receptor and Serum Corticosterone Expression in a Rodent Model of Noise-induced Hearing Loss: Comparison of Timing of Dexamethasone Administration.

Authors:  Seung-Hun Lee; Ah-Ra Lyu; Sun-Ae Shin; Seong-Hun Jeong; Sun-A Lee; Min Jung Park; Yong-Ho Park
Journal:  Sci Rep       Date:  2019-09-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.